Cellular Biomedicine Group, Inc. , a developer of proprietary cell therapies for the treatment of degenerative diseases and cancers, this week reported financial results and business highlights for the quarter and six months ended June 30, 2013.
http://www.freshnews.com/news/833688/cellular-biomedicine-group-reports-second-quarter-and-first-half-2013-financial-results
http://www.freshnews.com/news/833688/cellular-biomedicine-group-reports-second-quarter-and-first-half-2013-financial-results
No comments:
Post a Comment